FIELD: medicinal biotechnology, medicinal biochemistry. SUBSTANCE: invention relates to peptides and peptide analogues that simulate structural and pharmacological properties of human apolipoprotein (ApoA- 1). Peptides and peptide analogues represent amino acid sequences and multimeric complexes with lipids that can be used for treatment of different diseases associated with dyslipidemia. Invention describes pharmaceutical compositions and methods for treatment based on simulating agents of ApoA-1. EFFECT: valuable medicinal properties of agonists, expanded assortment of agents for control of dyslipidemia. 52 cl, 10 tbl, 8 dwg, 12 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AGONISTS OF APOLIPOPROTEIN A-I AND THEIR USING FOR TREATMENT OF DYSLIPIDEMIA-MEDIATED DISEASES | 1998 |
|
RU2215747C2 |
| AGONISTS OF APOLIPOPROTEIN A-1 AND THEIR USING IN TREATMENT OF DYSLIPIDEMIC DISORDERS | 1998 |
|
RU2214831C2 |
| GENE-THERAPEUTIC METHODS FOR ADMINISTRATION OF APOLIPOPROTEIN A-1 AGONISTS AND THEIR USING IN TREATMENT OF DYSLIPIDEMIC DISORDERS | 1998 |
|
RU2222545C2 |
| A-I APOLIPOPROTEIN MIMETICS | 2010 |
|
RU2532222C2 |
| JOINT LYOPHILIZATION-MEDIATED FORMATION OF PEPTIDE-LIPID COMPLEX | 1998 |
|
RU2224506C2 |
| INSULIN-INCRETIN CONJUGATES | 2014 |
|
RU2678134C2 |
| NEW DERIVATIVES OF OXYNTOMODULIN AND PHARMACEUTICAL COMPOSITION FOR TREATING OBESITY | 2012 |
|
RU2612906C2 |
| ANTIBACTERIAL PEPTIDES | 2007 |
|
RU2468033C2 |
| CONJUGATE OF LONG-ACTING PHYSIOLOGICALLY ACTIVE SUBSTANCE AND ITS USE | 2018 |
|
RU2773823C2 |
| CD40L-SPECIFIC CARCASS STRUCTURES DERIVED FROM Tn3, AND METHODS FOR USE THEREOF | 2012 |
|
RU2704992C2 |
